Elihu H. Estey
Fred Hutchinson Cancer Center
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Acute Myeloid Leukemia Research
Strong evidence · 3 supporting papers · latest 2025
Glioma Diagnosis and Treatment
Solid evidence · 1 supporting paper · latest 2025
Vascular Tumors and Angiosarcomas
Solid evidence · 1 supporting paper · latest 2025
Hematopoietic Stem Cell Transplantation
Solid evidence · 1 supporting paper · latest 2024
Acute Lymphoblastic Leukemia research
Solid evidence · 1 supporting paper · latest 2024
Histone Deacetylase Inhibitors Research
Solid evidence · 1 supporting paper · latest 2024
Chronic Myeloid Leukemia Treatments
Solid evidence · 1 supporting paper · latest 2024
Publications (3)
Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms
2024DOI
Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203
2025DOI
Phase I Trial Combining Venetoclax with Cladribine, Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) for Patients with Acute Myeloid Leukemia (AML) and High-Grade Myeloid Neoplasms
2024DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Fred Hutchinson Cancer Center
Source: OpenAlex · retrieved 2026-09-29
Source: ScienceWe Extractor · retrieved 2026-09-27